- Home
- About
- Section Advisors
- Meet Our Field Medical Affairs Team
- Speakers Bureau
- Supporting Organizations
- Contact Us
- Resource Library
- Mental Health Disorders
- Agitation
- Anxiety Disorders
- Bipolar Disorder
- Cognition
- Depression
- Eating Disorders
- Personality Disorders
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Women’s Health
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Early Episode Psychosis
- Health Care Policy & Legislation
- Neuroscience
- Payer & Financing Models
- Quality Standards & Performance Measures
- Stigma
- Suicide Awareness
- Wellness
- Collections
- Featured
- Monthly Spotlight
- Psychopharmacology
- Learning Tracks
- Community Insights
- Community Podcast
- Disease Management & Support Tools
- Frameworks In Health & Quality Resources
- Mental Health System Guidebooks
- Patient & Caregiver Resource Center
- PsychU Roleplay
- Psychiatric Scales
- PsychUSim
- Events
Virtual Event – Distinguishing Sedation From Efficacy In Antipsychotic Treatment
Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Distinguishing Sedation From Efficacy In Antipsychotic Treatment
This is a Virtual Event for PsychU members in Arizona; Las Vegas, Nevada; and San Diego, Imperial, Riverside and San Bernardino Counties, CA.
In this presentation, the objectives are to:
- Recognize the symptoms of acute agitation in an emergency department setting
- Understand the potential importance of minimizing sedation in the treatment of acute agitation in patients with schizophrenia
- Distinguish sedation from efficacy in antipsychotic treatment
- Understand the physiologic mechanisms for sedation and pharmacologic considerations when selecting an antipsychotic
Featuring
Michael Aldape, PhD (OPDC)
Senior Clinical & Scientific Liaison
John Awad, MD (OPDC)
Senior Clinical and Scientific Liaison
Speakers John Awad, MD, BPharm and Michael Aldape, PhD are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.
Related Events
-
Virtual Event – Strategies To Optimize Patient Outcomes In Bipolar 1 Disorder: The Role Of Long-Acting Injectable Antipsychotics
September 7 12:00 pm to 1:00 pm
Registration
Related Resources
-
Stigma & Bipolar Disorder: A Resource For Consumers
Downloadable Resource August 17, 2022This consumer resource discusses different types of stigma, how consumers may feel stigmatized by their condition, how stigma may impact treatment, and strategies to support treatment. Download Resource Frameworks…
-
Where Can I Find Help For My Mental Health Condition?
Downloadable Resource August 17, 2022This resource provides a list of national organizations that support consumers with mental health conditions by providing resources, services, and treatment options. Frameworks resources are intended for educational purposes only and…
-
Treatment For Bipolar Disorder: A Resource For Consumers
Downloadable Resource August 17, 2022This consumer resource discusses the importance of effective treatment plans, psychosocial interventions and medication therapy, suggested treatment goals, and support outlets for helping consumers lead fulfilling lives with bipolar disorder….
Stay Connected: